Brentuximab (Anti-TNFRSF8 / CD30)
A2322
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameBrentuximab (Anti-TNFRSF8 / CD30)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionBrentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.
- Storage Instruction-20°C
- UNSPSC12352203